Darrin Crisitello is the chief commercial officer of Quanterix. He received his BS in biology and chemistry from Moravian College and his MBA from the University of Massachusetts. He began his career in pharmaceuticals at Wyeth and Bristol-Myers Squibb, holding various positions in sales, sales operations, training, marketing, and management in several different therapeutic areas.
Crisitello then transitioned to startup organizations as a leader in business development, company commercialization, and had exits with several acquired companies. As the vice president of global sales at Natera, Crisitello led the launch of a non-invasive prenatal test, Panorama, and was part of the IPO in 2015. Crisitello launched the global clinical team at Color Health, a healthcare tech company democratizing access to high-quality genetic information and the “last mile” of healthcare. He also headed the commercial team at Mission Bio with their Tapestri Platform, which provides unprecedented insights into single-cell DNA sequencing and heterogeneity among cells that drive complex diseases like cancer. He is passionate about helping companies succeed and is an advisor for various invested companies.